Stock Track | Stevanato Group Shares Surge on Q3 Earnings Beat and Revenue Outlook

Stock Track

2024-11-05

Shares of Stevanato Group S.p.A. (NYSE: STVN), a leading producer of glass vials for COVID-19 vaccines, soared over 5% on Monday after the company reported better-than-expected third-quarter revenue and provided an optimistic full-year revenue outlook.

While the company's Q3 adjusted earnings of €0.12 ($0.13) per share narrowly missed analysts' estimates of €0.13, its revenue of €277.9 million surpassed the consensus estimate of €274.4 million. Stevanato attributed the revenue growth to strong demand for its pharmaceutical products.

For the full year 2024, Stevanato expects revenue in the range of €1.09 billion to €1.11 billion, in line with analysts' expectations of €1.09 billion. However, the company slightly lowered its adjusted earnings per share guidance to €0.47-€0.49, compared to the previous outlook of €0.48-€0.50.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1186717979"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1186717979\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1186717979?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-05 22:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186717979","market":"hk","top_or_hot":-1,"title":"Stock Track | Stevanato Group Shares Surge on Q3 Earnings Beat and Revenue Outlook","media":"Stock Track","content":"<p>Shares of Stevanato Group S.p.A. (NYSE: STVN), a leading producer of glass vials for COVID-19 vaccines, soared over 5% on Monday after the company reported better-than-expected third-quarter revenue and provided an optimistic full-year revenue outlook.</p>\n\n<p>While the company's Q3 adjusted earnings of €0.12 ($0.13) per share narrowly missed analysts' estimates of €0.13, its revenue of €277.9 million surpassed the consensus estimate of €274.4 million. Stevanato attributed the revenue growth to strong demand for its pharmaceutical products.</p>\n\n<p>For the full year 2024, Stevanato expects revenue in the range of €1.09 billion to €1.11 billion, in line with analysts' expectations of €1.09 billion. However, the company slightly lowered its adjusted earnings per share guidance to €0.47-€0.49, compared to the previous outlook of €0.48-€0.50.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Stevanato Group Shares Surge on Q3 Earnings Beat and Revenue Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Stevanato Group Shares Surge on Q3 Earnings Beat and Revenue Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2024-11-05 22:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Stevanato Group S.p.A. (NYSE: STVN), a leading producer of glass vials for COVID-19 vaccines, soared over 5% on Monday after the company reported better-than-expected third-quarter revenue and provided an optimistic full-year revenue outlook.</p>\n\n<p>While the company's Q3 adjusted earnings of €0.12 ($0.13) per share narrowly missed analysts' estimates of €0.13, its revenue of €277.9 million surpassed the consensus estimate of €274.4 million. Stevanato attributed the revenue growth to strong demand for its pharmaceutical products.</p>\n\n<p>For the full year 2024, Stevanato expects revenue in the range of €1.09 billion to €1.11 billion, in line with analysts' expectations of €1.09 billion. However, the company slightly lowered its adjusted earnings per share guidance to €0.47-€0.49, compared to the previous outlook of €0.48-€0.50.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"STVN","symbol_name":"Stevanato Group S.p.A.","start_time":0,"source_url":"","article_id":"1186717979","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186717979","pubTimestamp":1730818222,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Stevanato Group S.p.A. , a leading producer of glass vials for COVID-19 vaccines, soared over 5% on Monday after the company reported better-than-expected third-quarter revenue and provided an optimistic full-year revenue outlook.While the company's Q3 adjusted earnings of 0.12  per share narrowly missed analysts' estimates of 0.13, its revenue of 277.9 million surpassed the consensus estimate of 274.4 million. Stevanato attributed the revenue growth to strong demand for its pharmaceut","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"STVN":"Stevanato Group S.p.A."},"translate_title":"Stevanato Group股价因第三季度盈利超出预期和收入前景而飙升","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STVN":1},"content_text":"Shares of Stevanato Group S.p.A. (NYSE: STVN), a leading producer of glass vials for COVID-19 vaccines, soared over 5% on Monday after the company reported better-than-expected third-quarter revenue and provided an optimistic full-year revenue outlook.\nWhile the company's Q3 adjusted earnings of €0.12 ($0.13) per share narrowly missed analysts' estimates of €0.13, its revenue of €277.9 million surpassed the consensus estimate of €274.4 million. Stevanato attributed the revenue growth to strong demand for its pharmaceutical products.\nFor the full year 2024, Stevanato expects revenue in the range of €1.09 billion to €1.11 billion, in line with analysts' expectations of €1.09 billion. However, the company slightly lowered its adjusted earnings per share guidance to €0.47-€0.49, compared to the previous outlook of €0.48-€0.50.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}